TrialClinical and translational science2025

Effect of a Supratherapeutic Dose of Omaveloxolone on the Corrected QT Interval in Healthy Participants: A Randomized, Double-Blind, Placebo- and Active-Controlled, Three-Way Crossover Study.

Hamim Zahir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.